Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q35621678)
Watch
English
Results of lamivudine trials in Asia
scientific article published on January 2003
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
14708688
retrieved
9 August 2017
review article
1 reference
stated in
Europe PubMed Central
title
Results of lamivudine trials in Asia
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
14708688
retrieved
9 August 2017
main subject
lamivudine
1 reference
based on heuristic
inferred from title
author
Yun-Fan Liaw
series ordinal
1
0 references
publication date
1 January 2003
1 reference
stated in
Europe PubMed Central
PubMed ID
14708688
retrieved
9 August 2017
published in
Journal of Hepatology
1 reference
stated in
Europe PubMed Central
PubMed ID
14708688
retrieved
9 August 2017
volume
39 Suppl 1
1 reference
stated in
Europe PubMed Central
PubMed ID
14708688
retrieved
9 August 2017
page(s)
S111-5
1 reference
stated in
Europe PubMed Central
PubMed ID
14708688
retrieved
9 August 2017
cites work
Hepatitis B: global importance and need for control
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900155-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Natural history of hepatitis B virus infection in children.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900155-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B virus infection in Chinese families in Hong Kong.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900155-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900155-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis flares and hepatitis B e antigen seroconversion: implication in anti-hepatitis B virus therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900155-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chronic hepatitis B guidelines: east versus west
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900155-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900155-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The development of cirrhosis in patients with chronic type B hepatitis: A prospective study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900155-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900155-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A controlled trial of interferon with or without prednisone priming for chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900155-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Beneficial effect of prednisolone withdrawal followed by human lymphoblastoid interferon on the treatment of chronic type B hepatitis in Asians: a randomized controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900155-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of thymosin alpha1 in patients with chronic hepatitis B: a randomized, controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900155-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900155-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900155-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B. Asian Hepatitis Lamivudine Trial Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900155-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900155-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900155-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900155-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900155-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prednisolone priming enhances Th1 response and efficacy of subsequent lamivudine therapy in patients with chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900155-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effect of lamivudine therapy in hepatic decompensation during acute exacerbation of chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900155-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamivudine treatment for hepatitis B reactivation in HBsAg carriers after organ transplantation: a 4-year experience.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900155-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Results on preemptive or prophylactic treatment of lamivudine in HBsAg (+) renal allograft recipients: comparison with salvage treatment after hepatic dysfunction with HBV recurrence
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900155-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Preemptive use of lamivudine reduces hepatitis B exacerbation after allogeneic hematopoietic cell transplantation.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900155-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900155-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Consensus statements on the prevention and management of hepatitis B and hepatitis C in the Asia-Pacific region. Core Working Party for Asia-Pacific Consensus on Hepatitis B and C
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900155-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0168-8278(03)00155-7
1 reference
stated in
Europe PubMed Central
PubMed ID
14708688
retrieved
9 August 2017
PubMed ID
14708688
1 reference
stated in
Europe PubMed Central
PubMed ID
14708688
retrieved
9 August 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit